loadpatents
Patent applications and USPTO patent grants for LeBowitz; Jonathan.The latest application filed is for "hydrophobic peptide salts for extended release compositions".
Patent | Date |
---|---|
Hydrophobic Peptide Salts for Extended Release Compositions App 20220280647 - Ang; Jake ;   et al. | 2022-09-08 |
Lysosomal targeting peptides and uses thereof Grant 11,351,231 - LeBowitz , et al. June 7, 2 | 2022-06-07 |
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20220127326 - Aoyagi-Scharber; Mika ;   et al. | 2022-04-28 |
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 11,254,725 - Aoyagi-Scharber , et al. February 22, 2 | 2022-02-22 |
Lysosomal Targeting Peptides and Uses Thereof App 20210069304 - LeBowitz; Jonathan ;   et al. | 2021-03-11 |
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20190225666 - Aoyagi-Scharber; Mika ;   et al. | 2019-07-25 |
Targeted Therapeutic Proteins App 20190224282 - LeBowitz; Jonathan ;   et al. | 2019-07-25 |
Targeted therapeutic proteins Grant 10,300,113 - LeBowitz , et al. | 2019-05-28 |
Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins Grant 10,301,369 - Aoyagi-Scharber , et al. | 2019-05-28 |
Lysosomal Targeting Peptides and Uses Thereof App 20180125949 - LeBowitz; Jonathan ;   et al. | 2018-05-10 |
Targeted Therapeutic Proteins App 20180055911 - LeBowitz; Jonathan ;   et al. | 2018-03-01 |
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 9,845,346 - Aoyagi-Scharber , et al. December 19, 2 | 2017-12-19 |
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20170355744 - AOYAGI-SCHARBER; MIKA ;   et al. | 2017-12-14 |
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 9,834,588 - Aoyagi-Scharber , et al. December 5, 2 | 2017-12-05 |
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 9,834,587 - Aoyagi-Scharber , et al. December 5, 2 | 2017-12-05 |
Targeted therapeutic proteins Grant 9,814,762 - LeBowitz , et al. November 14, 2 | 2017-11-14 |
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 9,771,408 - Aoyagi-Scharber , et al. September 26, 2 | 2017-09-26 |
Lysosomal Targeting Peptides and Uses Thereof App 20170007680 - LeBowitz; Jonathan ;   et al. | 2017-01-12 |
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof Grant 9,376,480 - Aoyagi-Scharber , et al. June 28, 2 | 2016-06-28 |
Targeted Therapeutic Proteins App 20160152680 - LeBowitz; Jonathan ;   et al. | 2016-06-02 |
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20160039900 - Aoyagi-Scharber; Mika ;   et al. | 2016-02-11 |
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20160031964 - Aoyagi-Scharber; Mika ;   et al. | 2016-02-04 |
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20160031965 - Aoyagi-Scharber; Mika ;   et al. | 2016-02-04 |
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20160031963 - Aoyagi-Scharber; Mika ;   et al. | 2016-02-04 |
Targeted Therapeutic Proteins App 20150064183 - LeBowitz; Jonathan ;   et al. | 2015-03-05 |
Targeted therapeutic proteins Grant 8,859,498 - LeBowitz , et al. October 14, 2 | 2014-10-14 |
Formulations for lysosomal enzymes Grant 8,785,168 - LeBowitz , et al. July 22, 2 | 2014-07-22 |
Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof App 20140161788 - Aoyagi-Scharber; Mika ;   et al. | 2014-06-12 |
Targeted Therapeutic Proteins App 20140056867 - LeBowitz; Jonathan ;   et al. | 2014-02-27 |
Lysosomal targeting peptides and uses thereof Grant 8,563,691 - LeBowitz , et al. October 22, 2 | 2013-10-22 |
Targeted therapeutic proteins Grant 8,492,337 - LeBowitz , et al. July 23, 2 | 2013-07-23 |
Targeted therapeutic proteins Grant 8,492,338 - LeBowitz , et al. July 23, 2 | 2013-07-23 |
Formulations for Lysosomal Enzymes App 20120148556 - LeBowitz; Jonathan ;   et al. | 2012-06-14 |
Methods for Treating Pompe Disease App 20120093794 - LeBowitz; Jonathan ;   et al. | 2012-04-19 |
Methods and compositions for targeting proteins across the blood brain barrier Grant 7,981,864 - LeBowitz July 19, 2 | 2011-07-19 |
Acid alpha-glucosidase and fragments thereof Grant 7,785,856 - LeBowitz , et al. August 31, 2 | 2010-08-31 |
Methods for treating pompe disease App 20090117091 - LeBowitz; Jonathan ;   et al. | 2009-05-07 |
Acid alpha-glucosidase and fragments thereof App 20080299640 - LeBowitz; Jonathan ;   et al. | 2008-12-04 |
Methods and Compositions for Targeting Proteins Across the Blood Brain Barrier App 20080241118 - LeBowitz; Jonathan | 2008-10-02 |
Methods and compositions for targeting proteins across the blood brain barrier App 20060121018 - LeBowitz; Jonathan | 2006-06-08 |
Nuclear factors associated with transcriptional regulation App 20060063709 - Baltimore; David ;   et al. | 2006-03-23 |
Acid alpha-glucosidase and fragments thereof App 20050244400 - LeBowitz, Jonathan ;   et al. | 2005-11-03 |
Methods and compositions for targeting proteins across the blood brain barrier App 20030072761 - LeBowitz, Jonathan | 2003-04-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.